Purchase Order HHSN261201700407P

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $6,562.00 on March 20, 2018, with completion targeted for April 19, 2018. Performance is located in Leesburg, Virginia. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $14,797.00 on September 8, 2017, with ultimate completion on September 7, 2018. Performance occurs in Bethesda, Maryland. The order is fixed-price with economic price adjustment and carries no small business set-aside. The source does not specify the particular equipment, software, or services procured under this order.</p>

The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. valued at $14,999.00 on September 19, 2017, with final completion scheduled for September 18, 2018. The contract carries fixed-price pricing with economic price adjustment and no small business set-aside. Place of performance is Bethesda, Maryland. The order procures observational research tools and integrated solutions for behavioral analysis, including video-based tracking systems, automated...

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $11,688.50 on August 22, 2019, with ultimate completion on September 22, 2019. The order is for EthoVision XT, a video tracking and behavioral analysis software system. Place of performance is Leesburg, Virginia.</p>

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $22,064 on September 6, 2019, for a Dell Precision T3630 workstation, a set of four Phenotypers, an I/O box, a video digitizer board, and onsite installation and integration services. Performance will be completed at Leesburg, Virginia by December 5, 2019. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $7,821.75 on March 14, 2019, with an ultimate completion date of March 14, 2020. The order is firm fixed price with no set-aside designation. Place of performance is Gaithersburg, Maryland. The purchase order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH Office of Administrative Law and Management communication.</p>

<p>The National Cancer Institute awarded a purchase order to Leica Microsystems Inc. for $11,416.24 on September 23, 2020, with an ultimate completion date of October 28, 2020. The order is a firm fixed price acquisition with no set-aside designation. Performance occurs at Buffalo Grove, Illinois. The source does not specify the goods or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $24,158.08 on October 19, 2017, with an ultimate completion date of November 19, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific requirements are not detailed in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Ultraview Corporation valued at $9,995.00 on July 27, 2017. Work is performed at Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of August 20, 2017. No set-aside was used.</p>